Drugs / Fermented Papaya Preparation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT02771366 | Nov 2016 → Jul 2018 | — | University of Florida | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02051634 Comparator | Oct 2014 → Dec 2016 | autoinflammatory syndrome | University of Florida | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fermented Papaya Preparation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02051634 ↗ |
| Known as | FPP | “Participants will start taking the Fermented Papaya Preparation (FPP) three times per day, for 8 week.” NCT02771366 ↗1“Fermented Papaya Preparation (FPP)” NCT02051634 ↗ |
| Route | Oral | “Participants will open the sachet, slowly empty contents into their mouth, and let it dissolve before swallowing.” NCT02051634 ↗ |